Trial Profile
Prospective, randomized and controlled clinical trial comparing i.v. bolus application of Abciximab to i.c.application of Abciximab during primary PCU in patients with acute ST-elevation myocardial infarction.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Oct 2012
Price :
$35
*
At a glance
- Drugs Abciximab (Primary)
- Indications Embolism and thrombosis; Heart failure; Myocardial infarction
- Focus Therapeutic Use
- 18 Mar 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 26 Aug 2011 New trial record